MENU
RXRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Recursion Pharmaceuticals (RXRX) Ownership - Who owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more
Profile
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.33B
P/E Ratio
N/A
Total Cash
500.45M
Projected Growth
N/A
Total Debt
92.91M
Revenue
59.82M
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash/Share
1.15
Total Debt/Equity
N/A
Revenue/Share
0.18 USD as % of share price
Fundamentals
RXRX
Capitalization
2.33B
P/E Ratio
N/A
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash
500M
Total Cash/Share
1.15
Total Debt
92.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.18%
Revenue
59.8M
ROE
N/A
Book Value
934M
P/B Ratio
2.53
Cash Flow
N/A
Earnings
-1.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
4.11
Current Revenue Per Employee
18522.50
Dividends Per Share - Security
N/A
EBITDA
-524.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
-47.31
Revenue To Assets
-61.70
Shares Held By Institutions
4.62B
Shares Outstanding - Current
434M
Total Liabilities
371M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.710
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RXRX showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
41 S Rio Grande Street
Phone
+1 385 269-0203
Employees
500
Web
https://www.recursion.com